These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Intravenous immunoglobulin therapy for refractory ocular cicatricial pemphigoid: case report. Galdos M; Etxebarría J Cornea; 2008 Sep; 27(8):967-9. PubMed ID: 18724167 [TBL] [Abstract][Full Text] [Related]
3. A case of anti-BP180 type mucous membrane pemphigoid treated with intravenous immunoglobulin. Aoki N; Nakajima K; Shiga T; Koga H; Hashimoto T; Sano S J Dermatol; 2014 Jun; 41(6):557-9. PubMed ID: 24909219 [No Abstract] [Full Text] [Related]
4. Cost of intravenous immunoglobulin therapy versus conventional immunosuppressive therapy in patients with mucous membrane pemphigoid: a preliminary study. Daoud Y; Amin KG; Mohan K; Ahmed AR Ann Pharmacother; 2005 Dec; 39(12):2003-8. PubMed ID: 16264064 [TBL] [Abstract][Full Text] [Related]
5. Treatment of cicatricial pemphigoid with pulse intravenous cyclophosphamide. Musette P; Pascal F; Hoang-Xuan T; Heller M; Lok C; Deboise A; Dubertret L; Prost C Arch Dermatol; 2001 Jan; 137(1):101-2. PubMed ID: 11176680 [No Abstract] [Full Text] [Related]
6. Intravenous immunoglobulins for rituximab-resistant mucous membrane pemphigoid. Witte M; Zillikens D; Shimanovich I J Eur Acad Dermatol Venereol; 2018 Aug; 32(8):e321-e324. PubMed ID: 29443427 [No Abstract] [Full Text] [Related]
7. Intravenous immunoglobulin treatment in laryngeal pemphigoid. Gürcan HM; Ahmed AR Clin Exp Dermatol; 2009 Dec; 34(8):884-6. PubMed ID: 19094130 [TBL] [Abstract][Full Text] [Related]
8. Bullous and mucous membrane pemphigoid show a mixed response to rituximab: experience in seven patients. Lourari S; Herve C; Doffoel-Hantz V; Meyer N; Bulai-Livideanu C; Viraben R; Maza A; Adoue D; Bedane C; Paul C J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1238-40. PubMed ID: 21054575 [No Abstract] [Full Text] [Related]
9. [Mucous membrane pemphigoid. Guidelines for the diagnosis and treatment. Centres de référence des maladies bulleuses auto-immunes. Société Française de Dermatologie]. Bedane C; Prost C; Ingen-Housz-Oro S; Joly P; Bernard P; Ann Dermatol Venereol; 2011 Mar; 138(3):259-63. PubMed ID: 21397156 [No Abstract] [Full Text] [Related]
10. Dapsone efficacy and adverse events in the management of mucous membrane pemphigoid. Hegarty AM; Ormond M; Sweeney M; Hodgson T Eur J Dermatol; 2010; 20(2):223-4. PubMed ID: 20123643 [No Abstract] [Full Text] [Related]